Perplexity and Getty sign a multi-year licensing deal to integrate Getty's image library into Perplexity's AI tools, aiming to improve attribution and responsible AI usage.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Perplexity and Getty sign a multi-year licensing deal to integrate Getty's image library into Perplexity's AI tools, aiming to improve attribution and responsible AI usage.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.